Goldman Sachs stock edges up after Apple Card exit adds $0.46 to Q4 EPS — what to watch next
9 January 2026
2 mins read

Goldman Sachs stock edges up after Apple Card exit adds $0.46 to Q4 EPS — what to watch next

New York, January 9, 2026, 12:57 ET — Regular session

  • GS up roughly 0.5% around midday after Apple Card transition details surfaced
  • Apple Card deal seen adding roughly $0.46 to Q4 EPS, though net revenue takes a hit from write-downs and termination costs
  • Attention turns to Jan. 15 earnings and any commentary on deal fees, trading and costs

Goldman Sachs shares nudged up Friday after the bank said it has a deal to move the Apple Card program to JPMorgan Chase’s Chase, which JPMorgan and Apple said would shift more than $20 billion in card balances to Chase once the transition is finished. Goldman was up 0.5% at $939.12 by midday, versus a 0.1% gain for the Financial Select Sector SPDR ETF; JPMorgan and Morgan Stanley also traded higher. Goldman said the exit should lift fourth-quarter diluted earnings per share by about 46 cents, reflecting a $2.48 billion release of loan-loss reserves — money set aside for expected credit losses — partially offset by a $2.26 billion hit to net revenue from loan write-downs and contract-ending costs plus $38 million of expenses; CEO David Solomon said it “substantially completes” the narrowing of its consumer focus. 1

Timing is key. Big U.S. banks start reporting next week, with Goldman up on Jan. 15. Investors want to see whether a rebound in M&A and underwriting actually flowed through to fees, and whether markets revenue held up into year-end. A Reuters preview pegged global investment banking revenue up 15% in 2025 to almost $103 billion, and put global M&A volume at $5.1 trillion, up 42% from 2024. Stephen Biggar, a banking analyst at Argus Research, called the quarter a “perfect recipe” for investment banking revenue. 2

A regulatory filing showed Goldman tweaked its segment reporting beginning in the fourth quarter, shifting transaction banking into Global Banking & Markets and narrowing how it reports consumer-related activity within Platform Solutions. The bank said it recast segment results back to its 2021 fiscal year for comparability, a change that could alter how analysts follow Platform Solutions as Apple Card runs off. 3

On the dealmaking front, Goldman was also tapped alongside UBS on a planned initial public offering of CK Hutchison’s A.S. Watson unit, Bloomberg News reported, citing people familiar with the matter. Hong Kong logged its strongest IPO year since 2021 in 2025, with 114 new listings raising $36.5 billion, according to LSEG data cited by Reuters. 4

Macro could still tug the tape. A Reuters Week Ahead report said bank results and Tuesday’s U.S. consumer price index report will compete for investor attention, and it pointed to rising focus on what banks say about household finances. “The banks are going to be telling you something … pretty important because they’re on the front lines,” said Jack Janasiewicz, a portfolio manager at Natixis Investment Managers. 5

But the Apple Card handoff still needs regulatory approvals and will take time, keeping Goldman on the hook for any swing in consumer credit performance until the accounts move. A sharper-than-expected jump in delinquencies, or another market wobble that freezes IPOs and deal talks, would dent the fee story investors have been leaning on into earnings.

Goldman is set to report fourth-quarter results on Thursday, Jan. 15, with the release expected around 7:30 a.m. ET followed by a conference call at 9:30 a.m. ET, the bank said. Traders will be tuned in for signs of how quickly Platform Solutions shrinks, and whether momentum in advisory and underwriting can make up for any softer patches in wealth and financing. 6

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Builders FirstSource (BLDR) stock jumps as Trump’s $200B mortgage-bond order jolts housing names
Previous Story

Builders FirstSource (BLDR) stock jumps as Trump’s $200B mortgage-bond order jolts housing names

Why Regencell Bioscience (RGC) stock is moving today: choppy rebound after Nasdaq pauses
Next Story

Why Regencell Bioscience (RGC) stock is moving today: choppy rebound after Nasdaq pauses

Go toTop